A new clinical trial shows that deep brain stimulation (DBS) improved symptoms in half of adults with treatment-resistant depression, with one-third reaching remission.
Category: biotech/medical
Optimizing CAR T cell therapy for solid tumours: a clinical perspective
Chimeric antigen receptor (CAR) T cell therapy is revolutionizing the treatment of haematological malignancies, but expanding applicability to solid tumours presents substantial challenges. This Review describes key strategies to optimize CAR T cell therapy for solid tumours across areas spanning from target selection to response and safety evaluation.
Enzyme-free approach gently detaches cells from culture surfaces
Anchorage-dependent cells are cells that require physical attachment to a solid surface, such as a culture dish, to survive, grow, and reproduce. In the biomedical industry, and others, having the ability to culture these cells is crucial, but current techniques used to separate cells from surfaces can induce stresses and reduce cell viability.
“In the pharmaceutical and biotechnology industries, cells are typically detached from culture surfaces using enzymes—a process fraught with challenges,” says Kripa Varanasi, MIT professor of mechanical engineering. “Enzymatic treatments can damage delicate cell membranes and surface proteins, particularly in primary cells, and often require multiple steps that make the workflow slow and labor-intensive.”
Existing approaches also rely on large volumes of consumables, generating an estimated 300 million liters of cell culture waste each year. Moreover, because these enzymes are often animal-derived, they can introduce compatibility concerns for cells intended for human therapies, limiting scalability and high-throughput applications in modern biomanufacturing.
Targeted protein degradation: A new way to combat harmful proteins in tumor cells
A new active substance attacks a key protein in tumor cells, leading to complete degradation. In cell experiments, this caused cancer cells to lose their protection and die. The active substance was developed by researchers at the Martin Luther University Halle-Wittenberg (MLU) and the University Medical Center Mainz. Other substances usually try to inhibit the activity of the protein “checkpoint kinase-1” (CHK1). However, if the protein is completely broken down, a chain reaction is triggered which leads to other tumor proteins being destroyed. Thus, the cancer cells are further weakened.
The new study was published in Angewandte Chemie International Edition.
Usually, CHK1 is a vital protein for the human body. If errors occur during cell division and the genetic material is damaged, the protein halts the process so that the cell can repair it before proceeding. However, the protein does not distinguish between normal cells and tumor cells—it protects them equally.
Deep Learning-Enhanced Noninvasive Detection of Pulmonary Hypertension and Subtypes via Chest Radiographs, Validated by Catheterization
The central clock drives metabolic rhythms in muscle stem cells.
Sica et al. show that the circadian clock in the brain controls daily rhythms in muscle stem cells. These rhythms affect stem cell metabolism and repair capacity, even in the absence of a local clock. The findings reveal how central signals shape tissue-specific stem cell functions through systemic cues like feeding.
Psilocybin could reverse effects of brain injuries resulting from intimate partner violence, rat study finds
The term intimate partner violence (IPV) refers to physical, sexual or psychological abuse perpetrated by an individual on their romantic partner or spouse. Victims of IPV who are violently attacked and physically abused on a regular basis can sometimes present injuries that have lasting consequences on their mood, mental processes and behavior.
Common types of injuries observed in IPV victims who are periodically attacked physically include mild traumatic brain injuries (mTBI) and disruptions in the flow of blood or oxygen to the brain emerging from non-fatal strangulation (NFS). Both these have been linked to inflammation in the brain and a hindered ability to form new connections between neurons or change older connections (i.e., neuroplasticity).
Researchers at Monash University, Vancouver Island University and University of Victoria recently carried out a study involving rats aimed at assessing the potential of the psychedelic compound psilocybin for reversing the chronic effects of IPV-related brain injuries. Their findings, published in Molecular Psychiatry, suggest that psilocybin could in fact reduce inflammation and anxiety, improve memory and facilitate learning following brain injuries caused by repeated physical trauma.
Sharper MRI scans may be on horizon thanks to new physics-based model
Researchers at Rice University and Oak Ridge National Laboratory have unveiled a physics-based model of magnetic resonance relaxation that bridges molecular-scale dynamics with macroscopic magnetic resonance imaging (MRI) signals, promising new insight into how contrast agents interact with water molecules. This advancement paves the way for sharper medical imaging and safer diagnostics using MRI.
The study is published in The Journal of Chemical Physics.
This new approach, known as the NMR eigenmodes framework, solves the full physical equations that can be used to interpret how water molecules relax around metal-based imaging agents, a task that previous models approximated. These findings could alter the development and application of new contrast agents in both medicine and materials science.
Blocking one enzyme may break the link between alcohol and liver disease
Scientists discovered that alcohol activates a sugar-producing pathway in the body, creating fructose that may reinforce addictive drinking. The enzyme responsible, KHK, appears to drive both alcohol cravings and liver injury. When this enzyme was blocked in mice, their drinking decreased and their livers showed far less damage.
